key: cord-0888345-07n78qab
authors: Kates, Olivia S.; Stock, Peter G.; Ison, Michael G.; Allen, Richard D. M.; Burra, Patrizia; Jeong, Jong Cheol; Kute, Vivek; Muller, Elmi; Nino‐Murcia, Alejandro; Wang, Haibo; Wall, Anji
title: Ethical review of COVID‐19 vaccination requirements for transplant center staff and patients
date: 2021-11-15
journal: Am J Transplant
DOI: 10.1111/ajt.16878
sha: 01d5a72e12f81f7c7041f89f0e99be8af2d1c938
doc_id: 888345
cord_uid: 07n78qab

Transplant centers seeking to increase coronavirus disease 2019 (COVID‐19) vaccine coverage may consider requiring vaccination for healthcare workers or for candidates. The authors summarize current data to inform an ethical analysis of the harms, benefits, and individual and societal impact of mandatory vaccination, concluding that vaccine requirements for healthcare workers and transplant candidates are ethically justified by beneficence, net utility, and fiduciary duty to patients and public health. Implementation strategies should mitigate concerns about respect for autonomy and transparency for both groups. We clarify how the same arguments might be applied to related questions of caregiver vaccination, allocation of other healthcare resources, and mandates for non‐COVID‐19 vaccines. Finally, we call for effort to achieve global equity in vaccination as soon as possible.

for persons in arguments against mandates. 9 At least one transplant center in the United States has been named in the media as denying liver transplantation to a candidate who refused pretransplant COVID-19 vaccination. 10 We believe that it is essential to specify the ethical analysis of vaccine mandates for staff and candidates to the novel context of COVID-19 vaccination. Such policies have individual and public health implications, so we present an analysis incorporating individual-and public health-oriented bioethics principles, including non-maleficence, beneficence, and respect for autonomy; net utility, transparency, and justice. 11, 12 We first address COVID-19 vaccine mandates for transplant center staff, drawing on previous literature for influenza vaccines. Indeed, many of the ethical arguments supporting COVID-19 vaccine mandates for transplant center staff apply equally to all healthcare workers. We then address requirements for transplant candidates. We conclude by acknowledging the broader context surrounding proposed COVID-19 vaccine mandates, including vaccination of caregivers, use of vaccination status in allocation of other healthcare resources, mandates for other vaccines, and stark inequities in vaccine availability around the world.

Regarding the relationship between an individual healthcare worker and patient, it is a familiar tenet of all codes of medical ethics that the healthcare worker has a fiduciary duty to promote the wellbeing of the patient, and to not harm the patient. 13 Previous authors have argued that these duties establish an obligation for healthcare workers to be vaccinated and justify influenza vaccine mandates, whereas objections point out that there are few data demonstrating hypothesized benefits and harms. [14] [15] [16] For COVID-19, there have been confirmed nosocomial outbreaks beginning with asymptomatic healthcare workers or amplified by transmission chains involving healthcare workers resulting in patient illness and death. 17, 18 Transplant patients are particularly vulnerable, even if they are themselves vaccinated. [19] [20] [21] [22] [23] Infections among transplant candidates may lead to waitlist inactivation, missed transplant opportunities, or death; infections among transplant recipients may lead to death or graft loss. 24, 25 Additionally, transplant centers and other healthcare institutions have fiduciary obligations to protect their patients by overseeing vaccination among their staff.

The proposed duty of healthcare workers and institutions to protect patients through vaccination is in tension with healthcare workers' autonomy, although autonomy is not an absolute overriding ethical primary. 26 Mandates may also conflict with other expectations in the employer-employee relationship. Mandates applied with short notice may appear to abruptly change terms of employment for existing employees and conflict with an expectation for transparency, and mandates that are applied differently for different types of employees may conflict with an expectation for just treatment.

Even if all employees are treated the same, some will be affected differently by vaccine mandates because of differences in knowledge, for example, between clinical and nonclinical staff, differences in vaccination preferences, or differences in the probability of certain harms, such as thrombocytopenic thrombosis syndrome affecting mostly young women after vaccination with Ad26.COV2.S or ChAdOx1. 27, 28 Moreover, disparities in vaccination may overlap with other disadvantages in the healthcare workplace from racism, sexism, or power differentials between professional roles. 29 These concerns could be mitigated through thoughtful implementation strategies: providing sufficient time for employees to contemplate a vaccination decision, creating accessible educational materials for all members of the healthcare workforce, and allowing for reasonable medical objections to prevent serious harms.

Religious and philosophical objections, an exercise of autonomy, would not be supported on the basis of avoidance of harms, but may be legally protected in some settings. Importantly, vaccination would be expected to benefit, not harm healthcare workers; thus, mandatory vaccination is not in conflict with employers' duty to not harm their employees. Vaccination also promotes a safe working environment for all staff-most healthcare workplace-related severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures come from contact with other healthcare workers, whereas a minority come from contact with patients. 30, 31 Healthcare workers and institutions are also public health agents and should seek to promote the public health and not to detract from it. 12 Vaccinated healthcare workers can accomplish this directly through their participation in community immunity-in one US study, state laws promoting influenza vaccination for hospital workers were associated with a statistically significant decrease in population-level mortality from pneumonia and influenza. 32 In addition, reducing COVID-19 illnesses among healthcare workers ensures that more workers will be available to participate in patient care amidst ongoing surges. Vaccine mandates for healthcare workers can also have an indirect impact on public health by setting a positive example, broadcasting vaccine confidence, and building trust between public health agents and the population. 14 Bioethical obligations of beneficence, nonmaleficence and fidelity to patients and to the population favor and indeed necessitate healthcare worker vaccination, justifying some intrusion on healthcare worker autonomy. Experience with influenza vaccine requirements suggests that a COVID-19 vaccine requirement, rather than increasing convenience, education, or incentives, will be the most effective strategy for promoting vaccine uptake in settings where vaccines are already widely available. 

COVID-19 vaccine mandates raise unique considerations for transplant candidates. As has been shown for influenza vaccines and theorized for COVID-19 vaccines, pre-transplant vaccination can be expected to benefit candidates by conferring better protection than vaccination delayed until after transplant or no vaccination at all. 33 Transplant candidates can be expected to have high rates of seroconversion after COVID-19 vaccination (73%-88%), 34, 35 whereas transplant recipients have a reduced humoral response. 36, 37 Theoretical risks such as alloimmunization also have not been borne out with other vaccines, although vaccines do transiently impact assays of donor sensitization. 38 Overall, COVID-19 vaccines are safe for individuals with end-stage organ dysfunction, and strongly recommended to protect these patients from serious illness and death. 39 As for healthcare workers, exceptions should be made for serious medical contraindications to vaccination, where vaccination would be harmful to the candidate. date. In addition to risks related to COVID-19 infection, an additional hypothesized risk is that transplant candidates who refuse recommended vaccination will also be non-adherent to post-transplant instructions, although very limited data exist to evaluate this hypothesis. 40 One study found that families who refused childhood vaccination were also less likely to present for routine pediatric care, but whether this would be true for transplant-specific care or for individuals who refuse COVID-19 vaccines has never been tested. 41 Transplant centers should balance criteria to maximize net utility with attention to justice and equity, and listing criteria should 

Currently, COVID-19 vaccines are not available to most children around the world both because additional data are anticipated to support their use in some age groups and because children have not been prioritized for vaccination since they tend to have less severe COVID-19 illness when compared with adults. This holds true for pediatric transplant recipients who have less severe COVID-19 illness as compared with adult transplant recipients. 43 

The ethical arguments for COVID-19 vaccine mandates for either healthcare workers or transplant candidates might be extended in many directions. Transplant caregivers should seek to protect transplant recipients, and cocooning strategy of vaccinating close contacts is recommended for many vaccines. 44 However, transplant centers are not empowered to require caregivers to be vaccinated without imposing consequences harmful to candidates. Because caregiver vaccination status is not readily modifiable by the candidate, it is a less appropriate listing criterion than the candidate's own vaccination status, although both could be expected to improve candidate health, public health, and net utility from transplantation. The majority of available vaccines require a two-dose series for recipients to be considered fully vaccinated.

c Unpublished data from the Italian Health Ministry and update from National Transplant Center (CNT), Rome, Italy.

Landscape of observational study designs on the effectiveness of COVID-19 vaccination. who.int/ publications/m/item/draft-landscape-of-observational-studydesigns-on-the-effectiveness-of-covid-19-vaccination

Interventions to increase seasonal influenza vaccine coverage in healthcare workers: a systematic review and meta-regression analysis

Delta will require COVID-19 vaccine for new employees. Reuters

Hundreds of colleges say COVID vaccines will be mandatory for fall 2021. CNBC

Penn medicine to require all health system employees to receive COVID-19 Vaccine

Italy makes COVID-19 vaccine mandatory for all health workers

France passes law that makes a coronavirus health pass required for dining and travel

Constitutional rights in south africa protect against mandatory COVID-19 vaccination. Health Hum Rights J. hhrjo urnal. org/2021/04/const ituti onal-right s-in-south -afric a-prote ct-again st-manda tory-covid -19-vacci natio n

The limits of refusal: an ethical review of solid organ transplantation and vaccine hesitancy

Washington state man claims hospital refusing transplants to the unvaccinated

Defending the four principles approach as a good basis for good medical practice and therefore for good medical ethics

Public Health Code of Ethics

Bioethics: Principles, Issues, and Cases

To be or not to be vaccinated? The ethical aspects of influenza vaccination among healthcare workers

Adding justice to the clinical and public health ethics arguments for mandatory seasonal influenza immunisation for healthcare workers

Time to mandate influenza vaccination in health-care workers

Nosocomial outbreak of SARS-CoV-2 in a "Non-COVID-19" hospital ward: virus genome sequencing as a key tool to understand cryptic transmission

Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event

COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients

SARS-CoV-2 infection and early mortality of wait-listed and solid organ transplant recipients in England: a national cohort study

COVID-19 in solid organ transplant: a multi-center cohort study

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: no cause for alarm

Antibody response to the Janssen COVID-19 vaccine in solid organ transplant recipients

The COVID-19 outbreak in Italy: initial implications for organ transplantation programs

COVID-19 in Spain: transplantation in the midst of the pandemic

The ethics of public health practice: balancing private and public interest within tobacco policy

Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States

Vaxzevria (previously COVID-19 Vaccine AstraZeneca)

EPAR/vaxze vria-previ ously -covid -19-vacci ne-astra zeneca

COVID-19 vaccine acceptance among healthcare workers in a United States medical center

Use of whole-genome sequencing to investigate a cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in emergency department personnel

Nosocomial infection outbreak due to SARS-COV-2 in a hospital unit of particularly vulnerable patients

Population mortality and laws encouraging influenza vaccination for hospital workers

Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice

Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls

Immunogenicity of SARS-CoV-2 vaccine in dialysis

Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients

Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis

Safety and reactogenicity of 2 doses of SARS-CoV-2 vaccination in solid organ transplant recipients

Parental refusal of vaccination and transplantation listing decisions: a nationwide survey

The impact of vaccine refusal on physician office visits during the subsequent 12 months

SARS-CoV-2 variants in patients with immunosuppression

The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multiorgan case series

Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies

Tracking coronavirus vaccinations around the world. The New York Times

International Figures on Donation and Transplantation. Global Observatory on donation and transplantation

Italian association for the study of the liver position statement on SARS-CoV2 vaccination

Ethical review of COVID-19 vaccination requirements for transplant center staff and patients

The authors thank the following individuals for their thoughtful review of an early version of the manuscript: Curie Ahn (South Korea), Ian Dittmer (New Zealand), Riadh Fadhil (Qatar), Rudolf Garcia-Gallont (Guatemala), Ifeoma Ulasi (Nigeria), and Kristof Van Assche (Belgium).

The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. MGI received research support, paid to Northwestern University, from GlaxoSmithKline; he is a paid consultant for Adagio, AlloVir, Celltrion, Cidara, Genentech, Roche, Janssen, Shionogi, Viracor Eurofins; he is also a paid member of DSMBs from CSL Behring, Janssen, Merck, SAB Biotherapeutics, Sequiris, and Takeda. The other authors have no conflicts of interest to disclose.

No data were used in the production of this manuscript. Vivek Kute https://orcid.org/0000-0002-0002-2854

Anji Wall https://orcid.org/0000-0002-7359-1337